A combined subgroup analysis of the similar trials NOAH—AFNET 6 and ARTESiA has revealed that patients with device-detected atrial fibrillation and concomitant vascular disease are at higher ...

If you have atrial fibrillation (AFib), your doctor may suggest long-term blood thinners, also called anticoagulants. They lower your risk for stroke caused by a blood clot, the most dangerous ...

Non-valvular atrial fibrillation accounts for 13–26% of acute ischaemic strokes.1 Direct oral anticoagulants (DOACs) are ...

BOSTON -- In deciding on anticoagulation with apixaban (Eliquis) for patients with device-detected, subclinical atrial fibrillation (SCAF), one key number appeared to distinguish those for whom ...

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is ...

For people with atrial fibrillation (Afib or AF), stopping oral anticoagulation (OAC) after a "successful" catheter ablation left them exposed to increased risk, according to a Japanese hospital's ...

If you have paroxysmal AFib, you might not need anticoagulation therapy. Persistent AFib. AFib doesn’t end on its own and continues until you get medications or cardioversion.

Atrial fibrillation affects millions of people worldwide and significantly increases the risk of ischemic stroke. In this month's Viewpoint, Alan Go examines the use of anticoagulant therapy, the ...

Warfarin reduces the risk of stroke in atrial fibrillation by around 60%, while antiplatelet therapy is much less effective. Bleeding is, however, a notable adverse effect with warfarin.

Patients with atrial fibrillation who have experienced a stroke would benefit greatly from earlier treatment than is ...

DEAR DR. ROACH: I am a 70-year old woman with a prior history of asymptomatic atrial fibrillation (AFib). I’ve been in normal sinus rhythm since having two catheter ablations in 2018. I take ...

Source Reference: Iwawaki T, et al "Discontinuation of oral anticoagulation after successful atrial fibrillation ablation" JAMA Netw Open 2025; DOI: 10.1001/jamanetworkopen.2025.1320. Secondary Source ...